NSE seeks clarification on missing cash flow statement

Regulatory & Legal

VAISHALI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.5%1-day move

₹7.39

prior close

₹7.35

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.8-0.8-0.7+1.5-2.6-1.9-2.2-1.2+0.7+6.1+4.7——

Up moveDown movePending

AI summary

NSE has asked Vaishali Pharma to clarify why the Consolidated Statement of Cash Flow was not submitted with its March 2026 quarter results, under Regulation 33 of SEBI listing rules. The company's response is awaited.

Likely market impact

Minor compliance lapse flagged by the exchange. Not a penalty yet, but unresolved clarifications can dent investor sentiment.